AZN - AstraZeneca PLC (AZN) CEO Pascal Soriot on Q2 2021 Results - Earnings Call Transcript

AstraZeneca PLC (AZN) Q2 2021 Earnings Conference Call July 29, 2021 6:45 AM ET Company Participants Pascal Soriot - Executive Director and Chief Executive Officer Dave Fredrickson - EVP, Oncology Business Unit Ruud Dobber - EVP, BioPharmaceuticals Business Unit Marc Dunoyer - Executive Director and Chief Financial Officer Mene Pangalos - EVP, BioPharmaceuticals R&D Susan Galbraith - EVP, Oncology R&D Leon Wang - EVP, China and the Emerging Markets Aradhana Sarin - Chief Financial Officer elect Conference Call Participants Luisa Hector - Berenberg Tim Anderson - Wolfe Research Richard Parkes - Exane Keyur Parekh - Goldman Sachs Sachin Jain - Bank of America Andrew Baum - Citi Mark Purcell - Morgan Stanley Simon Baker - Redburn James Gordon - JPMorgan Emmanuel Papadakis - Deutsche Bank Seamus Fernandez - Guggenheim Steve Scala - Cowen Naresh Chouhan - Intron Health Viktor Sandberg - Svalner Presentation Operator Good afternoon, Europe and good morning

For further details see:

AstraZeneca PLC (AZN) CEO Pascal Soriot on Q2 2021 Results - Earnings Call Transcript